{"text": ["AbbVie", "reaches", "an", "agreement", "with", "the", "pan-Canadian", "Pharmaceutical", "Alliance", "(pCPA)", "for", "the", "Combination", "VENCLEXTA\u00ae", "With", "Rituximab", "as", "a", "Treatment", "for", "Patients", "With", "Chronic", "Lymphocytic", "Leukemia", "(CLL)"], "created_at": "2019-12-18 19:56:00"}
{"text": ["AbbVie", "Receives", "European", "Commission", "Approval", "of", "RINVOQ\u2122", "(upadacitinib)", "for", "the", "Treatment", "of", "Adults", "with", "Moderate", "to", "Severe", "Active", "Rheumatoid", "Arthritis"], "created_at": "2019-12-18 15:50:00"}
{"text": ["AbbVie\u2019s", "Humira", "Sales", "in", "Europe", "Appear", "to", "Be", "Holding", "Up", "Better", "Than", "Anticipated"], "created_at": "2019-12-18 14:53:00"}
{"text": ["ImmunoGen", "Lead", "Drug", "Gets", "Nod", "for", "Accelerated", "Approval", "Pathway"], "created_at": "2019-12-18 13:25:01"}
